Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERT-HBV: Preventing Vertical Transmission of Hepatitis B
NCT03567382Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by University of North Carolina at Chapel Hill. Started Sep 2018; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03567382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567382.